The European Commission’s pharmaceutical sector enquiry: was it really worth €100 million?
This article was originally published in SRA
Executive Summary
The final report on the European Commission’s pharmaceutical sector enquiry has now been published and has reiterated many of the criticisms against the originator industry that were initially raised in the preliminary report. However, to recall a question posed by one of the UK’s senior patent judges, Lord Justice Robin Jacob, has it taught us anything we did not already know?Faraz Kermani, Informa Business Information analyst, reports.